Pharma: Other News To Note
Tuesday, July 31, 2012
Forest Laboratories Inc., of New York, commented on the Delaware Court of Chancery's decision to deny investor Carl Icahn's demands for access to certain books and records of the company, stating that the firm is "pleased with the Court's decision," and adding that the firm will comply with the ruling, "which essentially gives Mr. Icahn the documents we had previously offered him."
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.